Nov 16 (Reuters) - CSL Ltd CSL.AX :
* NEW VACCINE MANUFACTURING FACILITY-CSL.AX
* SEQIRUS PLANS TO INVEST MORE THAN AUD$800 MILLION IN CONSTRUCTION OF A NEW BIOTECH MANUFACTURING FACILITY IN MELBOURNE
* CONSTRUCTION OF PLANT IS EXPECTED TO COMMENCE IN 2021 WITH FACILITY PROJECTED TO BE OPERATIONAL BY MID-2026
* FACILITY WILL ALSO MANUFACTURE SEQIRUS' PROPRIETARY ADJUVANT MF59